Valuation: Simcere Pharmaceutical Group Limited

Market Cap 380.06Cr 2.98TCr 326.2Cr 306.17Cr 279.64Cr 527.75Cr 36TCr 530.29Cr 3.62TCr 1.4TCr 18TCr 1.43TCr 1.4TCr 61TCr P/E 2026 *
14.5x
P/E 2027 * 12.6x
Enterprise Value 360.33Cr 2.82TCr 309.27Cr 290.28Cr 265.12Cr 500.35Cr 34TCr 502.76Cr 3.44TCr 1.33TCr 17TCr 1.35TCr 1.32TCr 57TCr EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.16x
Free-Float
32.13%
Yield 2026 *
3.62%
Yield 2027 * 4.11%
1 day+0.61%
1 week-6.98%
Current month-6.07%
1 month-8.88%
3 months+11.32%
6 months-10.77%
Current year-3.09%
1 week 11.34
Extreme 11.34
12.82
1 month 11.34
Extreme 11.34
13.12
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.55
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap.
13/07/26 Other

Founder

-47,000 0.0018%
13/07/26 Other

Director

-47,000 0.0018%
10/07/26 Other

Founder

-53,000 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-6.98%-21.62%+86.80% 377.76Cr
-1.17%-0.03%+18.70%+70.05% 4.84TCr
+1.12%+1.41%+54.88%+122.68% 3.99TCr
-1.36%-1.36%-11.21%+14.14% 1.2TCr
+2.27%+4.12%+16.41%+81.30% 1.18TCr
+0.19%0.00%+30.98%+150.00% 918.66Cr
-0.45%+3.26%+24.53%+45.36% 787.42Cr
+1.30%+1.26%+54.43%-10.73% 725.43Cr
+1.60%+8.54%+25.00%+217.84% 710.43Cr
+0.95%-8.22%-39.88%+16.67% 526.33Cr
Average +0.51%-0.14%+15.22%+79.41% 1.53TCr
Weighted average by Cap. +0.16%+0.95%+25.63%+85.42%

Financials

2026 *2027 *
Net sales 150.12Cr 1.18TCr 128.85Cr 120.94Cr 110.46Cr 208.46Cr 14TCr 209.46Cr 1.43TCr 554.65Cr 7.22TCr 563.65Cr 551.42Cr 24TCr 169.2Cr 1.33TCr 145.23Cr 136.31Cr 124.5Cr 234.95Cr 16TCr 236.09Cr 1.61TCr 625.15Cr 8.14TCr 635.3Cr 621.51Cr 27TCr
Net income 26Cr 200.09Cr 22Cr 21Cr 19Cr 35Cr 2.43TCr 36Cr 243.35Cr 94Cr 1.23TCr 96Cr 94Cr 4.07TCr 30Cr 236.47Cr 26Cr 24Cr 22Cr 42Cr 2.88TCr 42Cr 287.59Cr 111.45Cr 1.45TCr 113.26Cr 110.8Cr 4.81TCr
Net Debt -20Cr -154.67Cr -17Cr -16Cr -15Cr -27Cr -1.88TCr -28Cr -188.11Cr -73Cr -949.39Cr -74Cr -72Cr -3.14TCr -14Cr -109.54Cr -12Cr -11Cr -10Cr -19Cr -1.33TCr -19Cr -133.23Cr -52Cr -672.41Cr -52Cr -51Cr -2.23TCr
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,064
Date Price Change Volume
26/26/26 HK$11.60 +0.61% 58,82,000
25/26/25 HK$11.53 -0.60% 59,52,643
24/26/24 HK$11.60 -3.97% 51,91,643
21/26/21 HK$12.08 -0.98% 74,44,000
20/26/20 HK$12.20 +0.25% 1,40,74,000
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.949CNY
Average target price
15.11CNY
Spread / Average Target
+51.89%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock